America as we know it was built largely upon and because of our rail industry, and today it remains…
CFIF on X CFIF on YouTube
So-Called "Railway Safety Act" Constitutes a Political Handout to Big Labor That Does Nothing to Improve Safety At All

America as we know it was built largely upon and because of our rail industry, and today it remains a pillar of our economy.

Unfortunately, a destructive proposal before Congress misleadingly named the "Railway Safety Act" (RSA), part of broader surface transportation reauthorization, threatens great harm to our railroads.

Simply put, the bill has nothing to do with improving safety, but has a lot to do with advancing the political agenda of Big Labor.  At a moment when inflation burdens American families and fragile supply chains remain vulnerable to disruption, the last thing our economy or rail sector need is another costly federal mandate imposed upon one of the nation’s most important transportation sectors.

As an initial matter, as noted by The Wall Street Journal, the…[more]

May 20, 2026 • 04:28 PM
CFIF Reiterates Opposition to H.R. 3, Nancy Pelosi’s Socialized Medicine Bill Print
By CFIF Staff
Thursday, April 22 2021

 ALEXANDRIA, VA – Today, Democrats in the House of Representatives doubled down on Speaker Pelosi’s plan to impose a socialized drug pricing system that would import foreign price controls, stifle innovation and limit patient access by reintroducing H.R. 3, the deceptively-titled “Lower Drug Costs Now Act.”  What follows is a statement by CFIF President Jeffrey Mazzella: 

"CFIF unambiguously reiterates its opposition to this catastrophic legislation, which amounts to the worst and most far-reaching attempt yet to impose government control over Americans’ healthcare access.  

“As CFIF has been warning for years, H.R. 3 includes such mechanisms as foreign price controls, compulsory arbitration with government bureaucrats, a complete restructuring of the popular Medicare Part D program and what amounts to a retroactive 95% tax on many of the most commonly used medicines in America.  

“As CFIF has long highlighted, America enjoys – by far – the most innovative pharmaceutical industry in the world, accounting for two-thirds of all new life-saving and life-improving drugs globally.  But importing price controls from foreign nations – which ignore drug patents to extort compliance – would result in American consumers suffering the same drawbacks that consumers in those nations do. Namely, limited or no access to critical life-saving and life-improving drugs.  

“As even the United Nations World Health Organization (WHO) acknowledges, price controls suffocate innovation and delay the arrival of new drugs, or deny them entirely.  It’s therefore no accident that nations imposing price controls enjoy only a fraction of the new pharmaceuticals that Americans access, and that the United States outpaces those countries in terms of cancer survival rates and other benefits.  This bill also jeopardizes tens of billions of dollars spent annually on research and development by the pharmaceutical industry.  

“All of this is far too high a price for Americans to pay for Nancy Pelosi’s socialized medicine pet project.”  

CFIF is a constitutional and free market advocacy organization with over 300,000 supporters and activists nationwide.  

###

Notable Quote   
 
"Most Americans are well aware that living in debt -- consuming beyond what one can afford -- without a sustainable budget plan is haphazard; those who do so are often deemed to lack foresight. Collectively, Americans carry roughly $18.8 trillion in household debt. America's national debt, meanwhile, is more than double that amount.The amount owed by the U.S. government exceeds $290,000 per household…[more]
 
 
— Vladlena Klymova, Policy Analyst at the Taxpayers Protection Alliance
 
Liberty Poll   

Given the late implosion of U.S. Senate candidate Graham Platner in Maine, do you think voters, responsible media and the political parties will begin to seriously investigate political candidates earlier in the process?